Patents by Inventor Christopher J. M. Meade

Christopher J. M. Meade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090088408
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics, processes for preparing them and their use in the treatment of respiratory diseases.
    Type: Application
    Filed: August 29, 2008
    Publication date: April 2, 2009
    Inventors: Christopher J. M. Meade, Michel Pairet, Michael P. Pieper
  • Publication number: 20040151770
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: January 23, 2004
    Publication date: August 5, 2004
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Michel Pairet, Michael P. Pieper, Christopher J. M. Meade
  • Publication number: 20040058950
    Abstract: The present invention relates to novel pharmaceutical compositions based on new anticholinergics and PDE-IV inhibitors, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: July 7, 2003
    Publication date: March 25, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Christopher J. M. Meade, Michel Pairet, Michael P. Pieper
  • Publication number: 20040048887
    Abstract: The present invention relates to novel pharmaceutical compositions based on new anticholinergics and EGFR kinase inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.
    Type: Application
    Filed: July 7, 2003
    Publication date: March 11, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Christopher J. M. Meade, Michel Pairet, Michael P. Pieper
  • Publication number: 20040048886
    Abstract: The present invention relates to novel pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists, processes for preparing them and their use in the treatment of respiratory diseases.
    Type: Application
    Filed: July 7, 2003
    Publication date: March 11, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Christopher J. M. Meade, Michel Pairet, Michael P. Pieper
  • Publication number: 20040044020
    Abstract: The present invention relates to novel pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.
    Type: Application
    Filed: July 1, 2003
    Publication date: March 4, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Christopher J. M. Meade, Michel Pairet, Michael P. Pieper
  • Patent number: 6696042
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Grant
    Filed: April 21, 2003
    Date of Patent: February 24, 2004
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Michel Pairet, Michael P. Pieper, Christopher J. M. Meade
  • Publication number: 20040024007
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: July 3, 2003
    Publication date: February 5, 2004
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Michel Pairet, Christopher J. M. Meade, Michael P. Pieper
  • Publication number: 20030212075
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: April 21, 2003
    Publication date: November 13, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Michel Pairet, Michael P. Pieper, Christopher J. M. Meade
  • Publication number: 20030203925
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and endothelin antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: April 14, 2003
    Publication date: October 30, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Christopher J. M. Meade, Michel Pairet, Michael P. Pieper
  • Patent number: 6620438
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Grant
    Filed: March 6, 2002
    Date of Patent: September 16, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Michel Pairet, Michael P. Pieper, Christopher J. M. Meade
  • Patent number: 6608054
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and endothelin antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Grant
    Filed: March 18, 2002
    Date of Patent: August 19, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Christopher J. M. Meade, Michel Pairet, Michael P. Pieper
  • Publication number: 20030018019
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics, processes for preparing them and their use in the treatment of respiratory diseases.
    Type: Application
    Filed: June 17, 2002
    Publication date: January 23, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Christopher J.M. Meade, Michel Pairet, Michael P. Pieper
  • Publication number: 20020193393
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: March 7, 2002
    Publication date: December 19, 2002
    Inventors: Michel Pairet, Christopher J. M. Meade, Michael P. Pieper
  • Publication number: 20020183347
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and endothelin antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: March 18, 2002
    Publication date: December 5, 2002
    Inventors: Christopher J. M. Meade, Michel Pairet, Michael P. Pieper
  • Publication number: 20020169181
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: March 6, 2002
    Publication date: November 14, 2002
    Inventors: Michel Pairet, Michael P. Pieper, Christopher J. M. Meade
  • Patent number: 6197753
    Abstract: Pyranoside derivatives of the formula I wherein 1, m and n independently of one another denote an integer chosen from 0, 1, 2, 3 and 4 and 1+m+n≦4. These are are LTB4-antagonists. Also disclosed are processes for making these compounds.
    Type: Grant
    Filed: March 8, 1999
    Date of Patent: March 6, 2001
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans M. Jennewein, Christopher J. M. Meade, Andreas Ding
  • Patent number: 4874782
    Abstract: This invention provides certain furanone derivatives, their pharmaceutical formulations, and their use in a method for treating inflammation, asthma, or allergies.
    Type: Grant
    Filed: June 26, 1987
    Date of Patent: October 17, 1989
    Assignee: Eli Lilly and Company
    Inventors: Rosanne Bonjouklian, Christopher J. M. Meade, Edward D. Mihelich, Michael L. Phillips